GASTROESOPHAGEAL JUNCTION CANCER
Clinical trials for GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biosimilar aims to match cancer drug OPDIVO at lower cost
Disease control Not yet recruitingThis Phase 1 trial tests whether HLX18, a biosimilar of the cancer drug OPDIVO, works similarly in people with esophageal, melanoma, or bladder cancer after their tumors have been surgically removed. About 174 participants will receive either HLX18 or OPDIVO to compare how the dr…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New study tests if All-Keyhole surgery beats hybrid approach for esophageal cancer
Disease control Not yet recruitingThis phase 3 trial will compare two surgical techniques for esophageal cancer: totally minimally invasive esophagectomy (TMIE) using only keyhole incisions, versus a hybrid approach that combines keyhole and open chest surgery. The study aims to see if TMIE reduces severe complic…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New triple therapy could extend lives in stomach cancer
Disease control Not yet recruitingThis study tests a new drug called TST001 added to standard chemotherapy and immunotherapy for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if the combination helps control the tumor longer and improves surv…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE3 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Stomach-Saving surgery could help cancer patients keep weight on
Disease control Not yet recruitingThis study compares a new, less invasive surgery that removes only the cancerous upper part of the stomach to the standard full stomach removal. The goal is to see if the new approach helps patients lose less weight one year after surgery. The trial will enroll 120 adults with ea…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Targeted PET imaging could revolutionize cancer treatment selection
Diagnosis Not yet recruitingThis study tests a new PET imaging tracer, [68Ga]Ga-NODAGA-SNA014, to detect a protein called Claudin18.2 in pancreatic and stomach cancers. The goal is to see if the scan can accurately identify patients whose tumors have this protein, which could help doctors choose the right t…
Matched conditions: GASTROESOPHAGEAL JUNCTION CANCER
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC